检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:杨扬[1] 何威[1] 李颖[1] 何云志[1] 黄海[1] 林自华[1] 吴军[1] 杨进清[1]
机构地区:[1]第三军医大学新桥医院皮肤科,重庆400037
出 处:《第三军医大学学报》2007年第23期2219-2222,共4页Journal of Third Military Medical University
基 金:国家自然科学基金(30371298)~~
摘 要:目的探讨转化生长因子β(transforming growth factor-β,TGF-β)信号转导通路中受体活化Smads(Smad2,Smad3)在脂溢性角化病皮损区的表达及其意义。方法采用反转录-实时定量聚合酶链式反应(RT and quantitative Real-Time PCR)和免疫组化技术分别检测脂溢性角化病皮损和正常对照皮肤中Smad2及Smad3的mRNA和Smad1/2/3及磷酸化Smad2/3(p-Smad2/3)蛋白的表达情况。结果与正常对照皮肤组相比,脂溢性角化病皮损中Smad2、Smad3的mR-NA以及Smad1/2/3、p-Smad2/3的表达水平下降。结论脂溢性角化病中受体活化Smads(Smad2、Smad3)和p-Smad2/3表达下调可阻断TGF-β信号转导,可能使TGF-β抑制上皮增生的作用不能有效发挥,从而促进了脂溢性角化病表皮的过度增生。Objective To investigate the expression of receptor-activited Smads (Smad2, Smad3 ) and phosphorylated Smad2,3 (p-Smad 2/3) in seborrheic keratosis. Methods The skin tissues of seborrheic ker- atosis from 45 patients (25 males and 20 females, average age: 57.6 years, average course of disease: 3.8 years) who received no treatment before and normal skin tissues from 40 patients (22 males and 18 females, average age : 48 years) undergoing plastic surgery in our hospital were examined for the mRNA levels of Smad2 and Smad3 by quantitative real-time PCR, and the protein levels of Smadl/2/3 and p-Smad2/3 by immunohistochemistry. Results The mRNA levels of receptor-activited Smads ( Smad2, Smad3 ) and the protein levels of Smadl/2/3, p-Smad2/3 were significantly down-regulated in the skin tissues of seborrheic keratosis in com- parison with control tissues. Conclusion Down-regulation of receptor-activited Smads (Smad2, Smad3 ) and p-Smad2/3 might interfere TGF-β signal transduction pathway and contribute to formation of aberrant hyperplastic epidermis in seborrheic keratosis.
关 键 词:脂溢性角化病 转化生长因子Β 受体活化Smad SMAD2 SMAD3 p—Smad2/3 信号通路
分 类 号:R329-33[医药卫生—人体解剖和组织胚胎学] R730.23[医药卫生—基础医学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.216.224.98